GUARNERI, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.820
NA - Nord America 1.474
EU - Europa 1.245
SA - Sud America 532
AF - Africa 54
OC - Oceania 9
Totale 6.134
Nazione #
US - Stati Uniti d'America 1.402
SG - Singapore 1.147
IT - Italia 731
CN - Cina 640
BR - Brasile 440
HK - Hong Kong 332
VN - Vietnam 248
FR - Francia 190
NL - Olanda 149
KR - Corea 120
JP - Giappone 111
IN - India 68
GB - Regno Unito 41
BD - Bangladesh 37
AR - Argentina 34
CA - Canada 30
ID - Indonesia 27
DE - Germania 24
MX - Messico 23
FI - Finlandia 21
IL - Israele 18
EC - Ecuador 17
ZA - Sudafrica 15
ES - Italia 12
VE - Venezuela 12
CO - Colombia 11
PL - Polonia 11
SA - Arabia Saudita 11
IQ - Iraq 10
MA - Marocco 10
TR - Turchia 10
UA - Ucraina 9
EG - Egitto 8
RU - Federazione Russa 8
AU - Australia 7
CL - Cile 7
AT - Austria 5
CH - Svizzera 5
LV - Lettonia 5
AL - Albania 4
CR - Costa Rica 4
DZ - Algeria 4
JO - Giordania 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
PS - Palestinian Territory 4
PY - Paraguay 4
TH - Thailandia 4
TN - Tunisia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
MY - Malesia 3
PH - Filippine 3
PK - Pakistan 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
DJ - Gibuti 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SV - El Salvador 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 6.134
Città #
Singapore 683
Santa Clara 660
Hong Kong 329
Hefei 294
Lauterbourg 137
San Jose 118
Seoul 118
Beijing 100
Ashburn 94
Ho Chi Minh City 84
Tokyo 80
Milan 61
Hanoi 59
Los Angeles 54
São Paulo 47
Rome 45
New York 34
Dallas 28
Rio de Janeiro 26
Florence 23
Naples 23
Genoa 20
Turin 20
Mumbai 19
Helsinki 18
Haiphong 17
Minamishinagawa 17
Bengaluru 16
Bologna 16
Orem 16
Buffalo 14
Montreal 13
Palermo 12
Bitonto 11
Minamimotomachi 11
Amsterdam 10
Guayaquil 10
Pietragalla 10
Reggio Calabria 10
Biên Hòa 9
Brooklyn 9
Da Nang 9
Frankfurt am Main 9
Manchester 9
St Louis 9
London 8
Riyadh 8
Belo Horizonte 7
Chicago 7
Monmouth Junction 7
New Delhi 7
Bari 6
Catania 6
Denver 6
Dhaka 6
Elk Grove Village 6
Guangzhou 6
Guarulhos 6
Houston 6
Jakarta 6
Johannesburg 6
Mexico City 6
Phoenix 6
Thái Nguyên 6
Warsaw 6
Boston 5
Brasília 5
Cape Town 5
Fortaleza 5
Hải Dương 5
Livorno 5
Messina 5
Nuremberg 5
Padua 5
Querétaro 5
Reggio Emilia 5
Riga 5
Toronto 5
Vicenza 5
Zurich 5
Amman 4
Ankara 4
Asunción 4
Atlanta 4
Bangkok 4
Brescia 4
Can Tho 4
Cascina 4
Charlotte 4
Chennai 4
Istanbul 4
Jacksonville 4
Nha Trang 4
Nova Iguaçu 4
Novi Ligure 4
Poplar 4
Porto Alegre 4
Ramallah 4
Recife 4
Ribeirão Preto 4
Totale 3.694
Nome #
null 618
Neuroanatomia - Un approccio semplice e comprensibile 99
Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems 97
Variazioni dell'espressione di VAPB e dei suoi prodotti di clivaggio nei pazienti con Sclerosi Laterale Amiotrofica 93
null 76
DBI (DIAZEPAM BINDING INHIBITOR) - THE PRECURSOR OF A FAMILY OF ENDOGENOUS MODULATORS OF GABA-A RECEPTOR FUNCTION - HISTORY, PERSPECTIVES, AND CLINICAL IMPLICATIONS 75
Mediatori aminoacidici della retina 75
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. II Report 74
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse. 73
Eye drops of Ch-Cx carrier silibinin inducing protection in a model of Age-related Macular Disease (AMD). 73
CRISPR/Cas9 "CLN8 null" towards a dysfunctional autophagy in CLN8-associated neuronal ceroid lipofuscinosis diseases-ePoster # 4774 72
Topical application of choline-calix[4]arene nanocarrier of silibinin reduces retinal damage in a model of Age-Related Macular Disease. 70
Neurosteroidogenic pathways toward retinal neurodegeneration and neuroprotection 68
A bicistronic vector to study the effect of CLN8/VAPA interaction on cell physiology and eventually the pathology of CLN8-associated NLC diseases 68
The neurosteroid pregnenolone sulfate contributes to neuronal cell death 65
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 65
Expression of VAPB cleavage of products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis 61
Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina 60
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases 59
NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES 59
Facts News & Views Organo Ufficiale della Società Italiana di NeuroPsicoFarmacologia. Numero Speciale 57
Disfunzione autofagica precoce nella malattia da accumulo lisosomiale tipo ceroidolipofuscinosi associata al gene CLN8 56
Relazione finale progetto Studio della degenerazione retinica in corso di lipofuscinosi ceroidea neuronale (malattia di Batten) in topi MND , FIRB-MIUR / RBAU01E3SL_001, anno 2006 53
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. TELETHON Grant GGP16277 53
Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis 53
The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina 53
NEUROSTEROIDOGENESIS IN RAT RETINAS 52
CLN8 protein: a post-translation modification and subcellular distribution study for understanding CLN8 physiopathology 52
Neurosteroid synthesis: an early event in retinal neurodegeneration 51
Studi di biodisponibilità della Silibinina strutturata in nanoparticelle per la terapia di patologie retiniche neurodegenerative 51
null 51
Different early ER-stress responses in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 50
Low concentrations of silibinin and choline-calixarene or INU-C8-PEG carriers assembling silibinin promote antioxidant and antiapoptotic effects in neuronal and retinal epithelial cells. 50
Iron accumulation and retinal pathology: neuroprotection by diketopiperazines 50
Orphanet - Il portale delle malattie rare e dei farmaci orfani: The CLN8 variant late-infantile neuronal ceroid lipofuscinosis (CLN8-vLINCL): functional aspects of the CLN8 protein and characterization of the degenerative mechanisms . 49
Autophagy and mitophagy in the CLN8mnd mouse, a model of childhood neurodegenerative diseases 48
Effect of uridine of GABA receptors. 47
METHYL MERCURY ENHANCES TRITIUM LABELED DIAZEPAM BINDING IN DIFFERENT AREAS OF THE RAT BRAIN 47
Neglected CLN8 protein function in the neuronal ceroid lipofuscinoses (NCLs). 47
A potential interactome map of CLN8 protein involved in the late-infantile form of neuronal ceroid lipofuscinosis. 47
Effetti di nuove diketopiperazine in un modello in vivo di Degenerazione Maculare Senile 47
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with Vesicle-Associated Membrane Protein-associated Protein A (VAPA), and genotype-phenotype correlations 47
CNR Environment and Health Inter-departmental Project: present knowledge and prospects for future research. 46
null 44
HIPPOCRATES PON02_00355 Regione Sicilia - Sviluppo di Micro e Nano-Tecnologie e Sistemi Avanzati per la Salute dell'uomo. 44
Retinal oxidation and apoptosis in the motor neuron degeneration mouse, a model of neuronal ceroid lipofuscinosis 44
Does neurosteroidogenesis contribute to neuronal excitotoxicity? 43
Human neuroblastoma SH-SY5Y cell line: Neurosteroid-producing cell line relying on cytoskeletal organization 43
The role of autophagy in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 43
17b-estradiol synthesis in the adult male rat retina. 41
Tackling mechanisms of CLN8 mutations in neuronal ceroid lipofuscinosis (NCLs). 40
An early impact of ER stress, inflammation and oxidative stress in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis 40
Sustained release of silibinin to the posterior segment of the eye by mucoadhesive NLC 40
Identification of an antigen related to the sea urchin RNA-binding protein LP54 in mammalian central nervous system. 39
Structure specificity of ER stress in the Cln8-mnd mouse model of the late-infantile neuronal ceroid. 39
Riunione Annuale CLNet 39
CAMP/PKA-linked phosphorylation and cytoskeletal organization are required for cholesterol transport and neurosteroid synthesis in neuroblastoma SH-SY5Y cells 38
CLN8 interactors: a possible function of the CLN8 protein in the lipid metabolism and autophagy 38
The protective role of estrogen-receptor-beta in retinal excitotoxicity. 36
Analisi farmacologiche di nuovi sistemi nanoparticellari per il rilascio del blu di metilene con potenziali effetti nelle malattie neurodegenerative 36
Retinopatia diabetica sperimentale: ruolo dei gangliosidi. 35
TRAIL and TRAIL neutralizing antibody in the retina and RPE/choroid of the 3xTg-AD mouse model of Alzheimer disease. 35
Sistemi modello di patologie retiniche e neurodegenerative e strategie per la comprensione, la diagnosi e la terapia. 35
Execution pathways of pregnenolone sulfate-induced retinal apoptosis 34
TARGETING TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AMELIORATES RETINAL PATHOLOGY IN A TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE 34
La patogenesi delle varianti CLN8 nelle ceroidolipofuscinosi. 34
Peripheral-type benzodiazepine receptor role in the regulation of steroid and neurosteroid biosynthesis 34
Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis 34
Tumor necrosis factor-related apoptosis inducing ligand/glucocorticoid-induced TNF receptor ligand redundancy in neurodegenerative processes 33
Modelli retinici per le nanotecnologie e il biomonitoraggio ambientale 32
The protective role of Estrogen-Receptor-Beta in retinal excitotoxicity. 32
GAMMA-AMINOBUTYRIC-ACID TYPE-A BENZODIAZEPINE RECEPTORS REGULATE RAT RETINA NEUROSTEROIDOGENESIS 32
Ruolo degli estrogeni nella neuroprotezione della retina 31
CLN8 and VAPA, a possible protein-protein interaction at the ER for the regulation of lipid metabolism 31
High vulnerability of estrogen-producing retinal cells to excitotoxic insult: downregulation of P450 aromatase activity 31
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse 31
Orphanet - Il portale delle malattie rare e dei farmaci orfani: Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers . 31
PATHOGENIC MECHANISMS IN THE CLN8 FORM OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS. NEW INSIGHTS INTO THE VISUAL LOSS FROM THE CLN8mnd MOUSE MODEL 30
Prodotto l anticorpo anti-CLN8, proteina implicata in una patologia neurodegenerativa rara del bambino. 30
Structure specificity of ER stress in the CLN8-MND mouse model of the late-infantile neuronal ceroid lipofuscinosis. 30
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration 30
Modulation of neurosteroidogenesis by NMDA receptors is an early event involved in acute excitotoxicity 30
DeadEndTM Colorimetric apoptosis detection system for the analysis of retinal apoptosis 30
IN VIVO EFFECTS OF 17BETA-ESTRADIOL AND DHT ON THE RAT RETINA: A PROTEOMIC APPROACH 30
Uridina e complesso recettoriale GABA Benzodiazepine ionoforo. 29
Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity 29
Functional analysis of L-3H Iysine binding to the rat retina. 28
Neurosteroidogenic pathways toward retina neurodegeneration or neuroprotection 28
CLN8 and VAP-A, a possible protein-protein interaction at the ER for the regulation of lipid metabolism and with implication in neurodegenerative diseases. 28
TRITIATED L LYSINE BINDING TO RAT RETINAL MEMBRANE II. EFFECT OF KAINIC ACID D L-ALPHA AMINOADIPIC ACID IODOACETIC ACID AND MODIFICATION BY DARK-EXPOSURE 27
ER stress and inflammation, two interactive responses in neurodegenerative processes. 27
A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-speci.c caspase-2 activation in the retinal cell death 27
STRUCTURE SPECIFICITY OF ER STRESS IN THE CLN-MND MOUSE MODEL OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS 27
Progetto Invecchiamento "PNR-CNR Aging Program 2012-2014 PI.P02 "Invecchiamento: Innovazioni tecnologiche e molecolari per un miglioramento della salute dell'anziano" 27
FUNCTIONAL CHARACTERIZATION OF THE NEURONAL CEROID LIPOFUSCINOSIS CLN8 PROTEIN: INSIGHTS FROM THE SPLIT-UBIQUITIN MEMBRANE-BASED YEAST TWO-HYBRID SYSTEM 26
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system 26
INTERACTION OF URIDINE WITH GAMMA AMINO BUTYRIC-ACID BINDING SITES IN CEREBELLAR MEMBRANES OF THE RAT 26
Neurosteroids in retina: synthesis and neuronal function. 26
ENDOPLASMIC RETICULUM STRESS AND THE UNFOLDED PROTEIN RESPONSE IN THE Cln8mnd MOUSE MODEL OF NEURONAL CEROID LIPOFUSCINOSES (NCLS) 26
LDH, MDH, ATPasi nel sistema nervoso periferico di ratti sottoposti ad iperglicemia sperimentale. 26
Totale 5.046
Categoria #
all - tutte 17.801
article - articoli 6.018
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.000
Totale 24.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 17 3 5 6
2024/20252.485 14 9 162 120 635 62 29 71 121 151 598 513
2025/20263.621 209 400 342 575 637 128 492 230 250 189 155 14
Totale 6.137